• Username (E-mail)
  • Password
Dow 20,822 0.1%  EStoxx50 3,304 -0.9%  Nikkei 19,284 -0.5%  EUR 1.0562 -0.4% 
Nasdaq 5,845 0.2%  FTSE100 7,244 -0.4%  Yen 112.1440 0.0%  Oil 56.0 -0.8% 
S&P500 2,367 0.2%  DAX 11,804 -1.2%  GBP 1.2460 0.0%  Gold 1,257 0.6% 

Johnson & Johnson share [Symbol: JNJ / ISIN: US4781601046]

Realtimequote Johnson & Johnson in USD

Exchange Market
122.72
Last
728,005
Volume
Time 03:59 PM
02/24/2017 03:59:58 PM UTC-0500
activate push

Stock Price Johnson & Johnson in USD

Activate push
122.73 USD 1.03 USD 0.85 %
Trade Time 4:15 PM Trade Date 2/24/2017
Daily High 122.74 Open 121.85
Daily Low 121.42 Prev. Close 122.73
52-week High 126.07 Volume (Qty.) 3,280,595
52-week Low 105.05 Market Cap (USD) 330.14 B
52-week Perf.
Exchange

Analyst Opinions for Johnson & Johnson

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
06/13/16
Johnson & Johnson Goldman Sachs Group Inc.
01/27/16
Johnson & Johnson Independent Research GmbH
01/21/16
Johnson & Johnson Independent Research GmbH
07/02/14
Johnson & Johnson Barclays Capital
11/25/13
Johnson & Johnson Independent Research GmbH

Moody's Rating for Johnson & Johnson

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating Aaa
Rating Update AFF
Date of Rating 10/13/2015
Rating Office USA

Profile Johnson & Johnson

Company Profile
Johnson & Johnson is an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. The baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. These include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
pagehit

Add or Edit Instrument

Johnson & Johnson Chart - 1 Year - NYSE
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: NYSE
  • Chart Options

Estimates for Johnson & Johnson

2016 2017e 2018e
Dividend 3.15 3.34 3.55
Dividend Yield in % 2.71 2.81 2.98
P/E Ratio 17.24 16.89 16.01
EPS 6.73 7.05 7.43

Johnson & Johnson Key Figures

Market Cap (USD) 330.14 B
Free Float in % 99.89
Number of Shares (Mio.) 2,720.53
Cash Flow per Share 6.47
Book Value per Share 27.40
60-Days Volatility 14.53
P/B Ratio 4.24

Base Data Johnson & Johnson

Symbol JNJ
ISIN US4781601046
Indices S&P 100, NYSE US 100, Dow Jones, S&P 500, BX Swiss - USA

About the Company Johnson & Johnson

Country USA

Johnson & Johnson Historical Prices

02/22/2017
02/22/2017 06:00:00 PM UTC-0500
121.70 2,419,726
02/21/2017
02/21/2017 06:00:00 PM UTC-0500
119.52 1,802,444
02/20/2017
02/20/2017 06:00:00 PM UTC-0500
119.66 2,368,536
02/16/2017
02/16/2017 06:00:00 PM UTC-0500
118.86 3,390,168
02/15/2017
02/15/2017 06:00:00 PM UTC-0500
118.08 2,664,112

Johnson & Johnson Peer Group

Abbott Laboratories 45.68
0.6%
Alexion Pharmaceuticals 131.54
0.8%
AstraZeneca 46.16
0.3%
Bayer 104.55
-0.4%
Beiersdorf 86.55
-0.3%
Celgene 118.23
-1.0%
Fresenius Medical Care 77.84
-1.1%
Fresenius 75.79
-1.1%
Fresenius 75.79
-1.1%
Fresenius 75.79
-1.1%
GlaxoSmithKline 16.42
0.6%
Johnson & Johnson 122.73
0.8%
Merck 66.16
0.5%
Merck 103.20
0.3%
MorphoSys 51.89
-2.1%
Nestle SA 74.45
-0.3%
Novartis 77.45
-0.3%
Pfizer 34.26
0.6%
Procter & Gamble 91.05
-0.1%
Roche 248.10
-0.3%
STADA Arzneimittel 57.43
-0.5%
Sanofi 80.76
0.8%
Unilever 44.54
0.5%

Similar shares with higher 1-year perf.